US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
KNTE holding history
Kinnate Biopharma Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNTE overviewAll 13F holders of KNTEFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −113−100.0% | Sold out | Holders |
| Q4 2022 | 113 | $689 | <0.1% | −1,949−94.5% | Reduced | Holders |
| Q3 2022 | 2,062 | $25.0K | <0.1% | +83+4.2% | Added | Holders |
| Q2 2022 | 1,979 | $25.0K | <0.1% | +979+97.9% | Added | Holders |
| Q1 2022 | 1,000 | $11.0K | <0.1% | +1,000 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −100−100.0% | Sold out | Holders |
| Q3 2021 | 100 | $2.00K | <0.1% | +50+100.0% | Added | Holders |
| Q2 2021 | 50 | $1.00K | <0.1% | +50 | New | Holders |